K-ras gene mutations in liver carcinomas from a Mediterranean area of Spain

International Journal of Surgical Pathology

Volumn 8, Issue 4, 2000, Pages 267-270

  Boix Ferrero, Javier ^a   Pellin, Antonio ^a   Blesa, Jose Rafael ^a   Adrados, Manuel ^b   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; K ras mutation; Liver cancer

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; PREVALENCE; PRIORITY JOURNAL; SPAIN;

EID: 0034491730     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690000800405     Document Type: Article

References (19)

1. The molecular genetics of cancer
2. Function and regulation of ras
3. ras oncogenes in human cancer: A review
4. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
5. Prevalence of K-ras gene mutation in human colorectal cancers
6. Low incidence of point mutation of c-Kiras oncogenes in human hepatocellular carcinoma
7. Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangicarcinomas from a high-incidence area
8. Analysis of ras gene mutations in human malignant tumors by polymerase chain reaction and direct sequencing
9. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction
10. Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas
11. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma
12. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma
13. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides
14. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma
15. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis
16. Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by anti-sense sequences in rat liver
17. Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain
18. Point mutation of K-ras gene codon 12 in biliary tract tumors
19. Identification and characterization of genes associated with human hepatocellular carcinogenesis